Shares of MannKind Corporation (NASDAQ:MNKD) hit a 52-week high on Thursday as investors bet the government will approve the company’s flagship drug. MannKind Corporation (NASDAQ:MNKD) weekly performance is 17.43%. On last trading day company shares ended up $10.04. Analysts mean target price for the company is $8.58. MannKind Corporation (NASDAQ:MNKD) distance from 50-day simple moving average (SMA50) is 48.43%.
Gilead Sciences Inc. (NASDAQ:GILD) CFO Robin L. Washington sold 6,426 shares of the stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $82.52, for a total transaction of $530,273.52. Gilead Sciences, Inc. (NASDAQ:GILD) shares fell -0.26% in last trading session and ended the day on $82.80. GILD gross Margin is 77.80% and its return on assets is 19.10%.Gilead Sciences, Inc. (NASDAQ:GILD) quarterly performance is 3.60%.
On May 31, 2014, ARIAD Pharmaceuticals, Inc. (NASDAQ;ARIA) issued the first of four press releases announcing data presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois. This press release detailed preliminary safety and efficacy data from the discontinued Phase 3 EPIC trial of Iclusig (ponatinib) vs. imatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia (CML). Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares moved up 2.14% in last trading session and was closed at $6.69, while trading in range of $6.56 – $6.74. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) year to date (YTD) performance is -1.91%.
Illumina, Inc.(NASDAQ:ILMN) is up nearly 4% Thursday afternoon after the genetics and genotyping firm said late Wednesday it will sell $900 million aggregate principal amount of convertible senior notes. Of the total offering, Illumina proposes to offer $450 million aggregate principal amount of convertible senior notes due 2019 and $450 million aggregate principal amount of convertible senior notes due 2021. Illumina, Inc. (NASDAQ:ILMN) ended the last trading day at $164.09. Company weekly volatility is calculated as 3.94% and price to cash ratio as 19.30.Illumina, Inc. (NASDAQ:ILMN) showed a positive weekly performance of 2.64%.
Shares of Novavax Inc. (NASDAQ:NVAX) briefly fell to a 10% loss this morning, but have since stabilized at a loss of roughly 7%, following the release of yesterday’s post-market news that Novavax would issue a secondary offering of $100 million in new stock. Novavax, Inc. (NASDAQ:NVAX) weekly performance is -7.94%. On last trading day company shares ended up $4.52. Analysts mean target price for the company is $11.00. Novavax, Inc. (NASDAQ:NVAX) distance from 50-day simple moving average (SMA50) is 4.66%.